Recursion Pharmaceuticals
literature drives discovery informs target based hypotheses data are an exhaust limited to testing hypotheses disparate data generation to individual programs and diseases linear process little cross program learning or iteration bespoke processes low dimensional assays platforms drive discovery unbiased target agnostic data are our fuel shape our hypotheses connected data across programs relatable high dimensional data virtuous cycles of atoms bits iterative feedback accelerates learning industrialized to scale standardization recursion map based approach is designed set the standard for drug in the century | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
22 of 143
Related slides by other companies
AvePoint
Investor Presentation
March 2023
industry role based process productivity people collaborate with confidence a dee | AvePoint
Sportradar
IPO
September 2021
data and proprietary technology power advanced and machine learning | Sportradar
AbCellera
Investor Conference
April 2023
discovery programs high volume deals with highly diversified positions and high roi | AbCellera
Absci
Investor Presentation
October 2023
internal program partnerships have attractive risk return profiles | Absci
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io